LIGAND PHARMACEUTICALS INCORPORATED Goodwill
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Goodwill of $101.54 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:Goodwill · last filed 2026-08-07
- 2026-06-30: Goodwill $101.54M.
- 2026-03-31: Goodwill $101.54M.
- 2025-12-31: Goodwill $101.54M.
- 2025-09-30: Goodwill $101.54M.
| Period end | Goodwill | Goodwill as first filed |
|---|---|---|
| 2026-06-30 | $101.54M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $101.54M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $101.54M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $101.54M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $101.54M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $101.54M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $105.25M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $105.25M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $105.25M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $105.25M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $103.37M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $103.77M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $105.67M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $105.67M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $0.00 10-K · filed 2025-02-28 | $105.67M 10-K · filed 2023-02-28 |
| 2022-09-30 | $181.21M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $181.21M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $181.21M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $105.67M 10-K · filed 2023-02-28 | $181.21M 10-K · filed 2022-02-28 |
| 2021-09-30 | $190.18M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $190.52M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $190.51M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $189.66M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $102.14M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $103.37M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $94.34M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $95.23M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $93.51M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $88.00M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $86.81M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $86.65M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $85.96M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $85.96M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $85.96M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $85.96M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $72.21M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $72.21M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $72.21M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $72.21M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $72.36M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $72.36M 10-Q · filed 2016-11-14 | |
| 2016-03-31 | $73.00M 10-Q · filed 2016-11-14 | |
| 2015-12-31 | $12.24M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $12.24M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $12.24M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $12.24M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $12.24M 10-K · filed 2016-11-14 | |
| 2014-09-30 | $12.24M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $12.24M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $12.24M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $12.24M 10-K · filed 2015-02-23 | |
| 2013-09-30 | $12.24M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $12.24M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $12.24M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $12.24M 10-K/A · filed 2014-12-12 | |
| 2012-09-30 | $12.24M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $12.24M 10-Q/A · filed 2012-11-14 | $14.89M 10-Q · filed 2012-08-08 |
| 2012-03-31 | $12.24M 10-Q/A · filed 2012-11-14 | $14.89M 10-Q · filed 2012-05-04 |
| 2011-12-31 | $12.24M 10-K · filed 2013-03-14 | $14.89M 10-K · filed 2012-02-23 |
| 2010-12-31 | $700.00K 10-K/A · filed 2012-11-14 |